# Saratoga Investment Corp.: financial statements, quarterly

SAR · NYSE · CIK 1377936 · [Other](/sectors/other.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/sar.md) · [Financials](/companies/sar/financials.md) · [Filings](/companies/sar/filings.md) · [Insiders](/companies/sar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sar/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [0.9](/filings/0001213900-24-002282.md) | not reported | [0.3](/filings/0001213900-25-062051.md) | [0.5](/filings/0001213900-25-097022.md) | not reported | not reported | [0.8](/filings/0001213900-25-062051.md) | [0.9](/filings/0001213900-25-097022.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001213900-25-002065.md) | [0.1 d](/filings/0001213900-26-052176.md) | [(0.1)](/filings/0001213900-25-062051.md) | [0.1](/filings/0001213900-25-097022.md) | [0.0](/filings/0001213900-26-002153.md) | [0.3 d](/filings/0001213900-26-052176.md) | [0.1](/filings/0001213900-26-075931.md) | [(0.0)](/filings/0001213900-26-107187.md) | [(0.2)](/filings/0001213900-26-002153.md) | [0.0 d](/filings/0001213900-26-052176.md) | [(0.0)](/filings/0001213900-26-075931.md) | [0.0](/filings/0001213900-26-107187.md) |
| Net income | $m | [(4.1)](/filings/0001213900-25-002065.md) | [5.3 d](/filings/0001213900-26-052176.md) | [6.6](/filings/0001213900-25-062051.md) | [13.3](/filings/0001213900-25-097022.md) | [8.8](/filings/0001213900-26-002153.md) | [(0.7) d](/filings/0001213900-26-052176.md) | [13.9](/filings/0001213900-26-075931.md) | [13.3](/filings/0001213900-26-107187.md) | [12.0](/filings/0001213900-26-002153.md) | [(2.6) d](/filings/0001213900-26-052176.md) | [(6.9)](/filings/0001213900-26-075931.md) | [(6.7)](/filings/0001213900-26-107187.md) |
| Diluted EPS | $ per share | [(0.31)](/filings/0001213900-25-002065.md) | not reported | [0.48](/filings/0001213900-25-062051.md) | [0.97](/filings/0001213900-25-097022.md) | [0.64](/filings/0001213900-26-002153.md) | not reported | [0.91](/filings/0001213900-26-075931.md) | [0.84](/filings/0001213900-26-107187.md) | [0.74](/filings/0001213900-26-002153.md) | not reported | [(0.42)](/filings/0001213900-26-075931.md) | [(0.41)](/filings/0001213900-26-107187.md) |
| Basic EPS | $ per share | [(0.31)](/filings/0001213900-25-002065.md) | not reported | [0.48](/filings/0001213900-25-062051.md) | [0.97](/filings/0001213900-25-097022.md) | [0.64](/filings/0001213900-26-002153.md) | not reported | [0.91](/filings/0001213900-26-075931.md) | [0.84](/filings/0001213900-26-107187.md) | [0.74](/filings/0001213900-26-002153.md) | not reported | [(0.42)](/filings/0001213900-26-075931.md) | [(0.41)](/filings/0001213900-26-107187.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [21.4](/filings/0001213900-24-002282.md) | [8.7](/filings/0001213900-26-052176.md) | [32.2](/filings/0001213900-24-060116.md) | [84.6](/filings/0001213900-24-086270.md) | [148](/filings/0001213900-25-002065.md) | [148](/filings/0001213900-26-052176.md) | [132](/filings/0001213900-25-062051.md) | [106](/filings/0001213900-25-097022.md) | [52.3](/filings/0001213900-26-002153.md) | [1.7](/filings/0001213900-26-107187.md) | [46.1](/filings/0001213900-26-075931.md) | [80.1](/filings/0001213900-26-107187.md) |
| Total assets | $m | [1,172](/filings/0001213900-24-002282.md) | [1,191](/filings/0001213900-25-040617.md) | [1,202](/filings/0001213900-24-060116.md) | [1,215](/filings/0001213900-24-086270.md) | [1,220](/filings/0001213900-25-002065.md) | [1,192](/filings/0001213900-26-052176.md) | [1,202](/filings/0001213900-25-062051.md) | [1,206](/filings/0001213900-25-097022.md) | [1,197](/filings/0001213900-26-002153.md) | [1,139](/filings/0001213900-26-107187.md) | [1,197](/filings/0001213900-26-075931.md) | [1,256](/filings/0001213900-26-107187.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [799](/filings/0001213900-25-062051.md) | [806](/filings/0001213900-25-062051.md) | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | not reported | [821](/filings/0001213900-25-040617.md) | [834](/filings/0001213900-24-060116.md) | not reported | [845](/filings/0001213900-25-002065.md) | [799](/filings/0001213900-26-052176.md) | not reported | [796](/filings/0001213900-25-097022.md) | [784](/filings/0001213900-26-002153.md) | [743](/filings/0001213900-26-107187.md) | [819](/filings/0001213900-26-075931.md) | [904](/filings/0001213900-26-107187.md) |
| Long-term debt | $m | [0.8](/filings/0001213900-24-002282.md) | not reported | not reported | not reported | [838](/filings/0001213900-25-002065.md) | [794](/filings/0001213900-25-040617.md) | [791](/filings/0001213900-25-062051.md) | [786](/filings/0001213900-25-097022.md) | [774](/filings/0001213900-26-002153.md) | [739](/filings/0001213900-26-052176.md) | [817](/filings/0001213900-26-075931.md) | [902](/filings/0001213900-26-107187.md) |
| Shareholders' equity | $m | [360](/filings/0001213900-25-040617.md) | [370](/filings/0001213900-26-052176.md) | [368](/filings/0001213900-25-040617.md) | [372](/filings/0001213900-25-097022.md) | [375](/filings/0001213900-26-002153.md) | [393](/filings/0001213900-26-107187.md) | [396](/filings/0001213900-26-075931.md) | [410](/filings/0001213900-26-107187.md) | [413](/filings/0001213900-26-002153.md) | [396](/filings/0001213900-26-107187.md) | [378](/filings/0001213900-26-075931.md) | [353](/filings/0001213900-26-107187.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(18.6) d](/filings/0001213900-25-002065.md) | [(20.7) d](/filings/0001213900-26-052176.md) | [52.1](/filings/0001213900-25-062051.md) | [71.1 d](/filings/0001213900-25-097022.md) | [94.2 d](/filings/0001213900-26-002153.md) | [(19.9) d](/filings/0001213900-26-052176.md) | [32.3](/filings/0001213900-26-075931.md) | [(19.3) d](/filings/0001213900-26-107187.md) | [(8.6) d](/filings/0001213900-26-002153.md) | [(92.4) d](/filings/0001213900-26-052176.md) | [(26.0)](/filings/0001213900-26-075931.md) | [(27.8) d](/filings/0001213900-26-107187.md) |
| Dividends paid | $m | [8.4 d](/filings/0001213900-25-002065.md) | [8.9 d](/filings/0001213900-26-052176.md) | [9.0](/filings/0001213900-25-062051.md) | [9.1 d](/filings/0001213900-25-097022.md) | [9.0 d](/filings/0001213900-26-002153.md) | [13.7 d](/filings/0001213900-26-052176.md) | [16.7](/filings/0001213900-26-075931.md) | [10.5 d](/filings/0001213900-26-107187.md) | [10.8 d](/filings/0001213900-26-002153.md) | [14.4 d](/filings/0001213900-26-052176.md) | [10.8](/filings/0001213900-26-075931.md) | [10.8 d](/filings/0001213900-26-107187.md) |
| Share repurchases | $m | [0.0 d](/filings/0001213900-25-002065.md) | [0.0 d](/filings/0001213900-26-052176.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.2](/filings/0001213900-24-086270.md) | [13.1](/filings/0001213900-25-002065.md) | [13.7](/filings/0001213900-25-062051.md) | [13.7](/filings/0001213900-25-097022.md) | [13.8](/filings/0001213900-26-002153.md) | [15.3](/filings/0001213900-26-075931.md) | [15.8](/filings/0001213900-26-107187.md) | [16.1](/filings/0001213900-26-002153.md) | [16.3](/filings/0001213900-26-075931.md) | [16.2](/filings/0001213900-26-107187.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,559,638 at 2026-10-05, from the cover of the [10-Q filed 2026-10-06](/filings/0001213900-26-107187.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.